版權(quán)說(shuō)明:本文檔由用戶(hù)提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、研究用腫瘤細(xì)胞系的質(zhì)量控制和要求,中國(guó)醫(yī)學(xué)科學(xué)院基礎(chǔ)醫(yī)學(xué)研究所劉玉琴,Some Facts about the use of cultured cells-- Nobel prize,2001,Cell cycle2002, apoptosis2006, RNA Interference2007, homologous recombination and gene targeting2008,HPV—cervical ca,
2、 HIV--aids2009, telomere &telomerase,Nobel prize winner, use in vitro cultured cells for their researches.,現(xiàn)代生命科學(xué)研究中培養(yǎng)細(xì)胞的使用越來(lái)越廣泛,1969~2004:cell use increasing steadilyPapers use cells increase 2~2.5X biology, phar
3、macology and medicine---- tumor research不可少的研究材料、對(duì)象、工具Use of contaminated or misidentified cells increase 10X,Common problems,microbiological contamination with particular respect to mycoplasma infections (incidence o
4、f ca. 25%)cross-contamination by other cell lines and misidentification or misclassification (incidence of more than 15%)acquisition of genetic and epigenetic variations due to over-passaging of cell lines leading to a
5、 genetic drift of cell cultures and to the selection of altered subclones.,Where from?,faulty cell culture techniques: shared reagents, repeated use of the same pipette during re-feeding operations and manipulation of mu
6、ltiple cultures at the same time without adequate isolation of one cell type from another. the introduction of false, contaminated or over-passaged cell lines from other sources into the cell culture laboratory (35% )M
7、islabeling, lack of awarenessIntentional co-cultivation during propagation of human stem or primary cells using a feeder layer derived from another species,細(xì)胞交叉污染歷史回顧,1968,Apparent HeLa cell contamination of human heter
8、oploid cell lines.Nature.217:750-7511974,HeLa cess contaminating cultures around the world,Sciences 184:10591981, Contaminated cell cultures. Nature 289:2271981,cross-contamination of cells in culture. Sciences. 212(4
9、493):226-52,細(xì)胞交叉污染歷史回顧,1999, False human hematopoietic cell lins: cross-cantaminations and misint erpretations. Leukemia.13(10):1601-72003, False leukmia –lymphoma cell lines :an update on over 500 cell lines. Leukemia
10、17, 416-4262004,cell line cross-comtamination:how aware are…in vitro cell dev biol anim.40(7):211-52007,Cases of mistaken identity.Sciences 315:928-9312009, Nature calls for global database of cell line STR profiles,保
11、藏機(jī)構(gòu)公布的錯(cuò)誤細(xì)胞1,保藏機(jī)構(gòu)公布的錯(cuò)誤細(xì)胞2,保藏機(jī)構(gòu)公布的錯(cuò)誤細(xì)胞3,保藏機(jī)構(gòu)公布的錯(cuò)誤細(xì)胞4,保藏機(jī)構(gòu)公布的錯(cuò)誤細(xì)胞5,保藏機(jī)構(gòu)公布的錯(cuò)誤細(xì)胞6,DSMZ 德國(guó)細(xì)胞庫(kù),550 leukemia and lymphoma cell lines submitted59/395(15%) by originators23/155(15%) by secondary sources,交叉污染細(xì)胞使用的后果,Erroneous re
12、sults: Wasted research moneyPotential delay in discovery,錯(cuò)誤細(xì)胞使用,2000-2004:19/Int 407; 45/WISH; 59/Chang liver; 470/Hep-2; 556/KB; 2004(Buehring ), pubmed search 220publications involved, 32% use HeLa cells,33% tested
13、for authenticity, 35% get cells from other labs.NCI panel of 60 cell lines were used for anticancer drug evaluation. Among them ADR-RES is acutally OVCAR-8. It had been used in about 300 papers.,HeLa cervical cancer ce
14、lls,Int-407 (described as “non-transformed intestinal epithelial cells”) in Br. J. Cancer 101, 1596(2009), EMBO J. 22, 5003 (2003) and J. Biol. Chem. 280, 13538 (2005) WISH (described as “non-transformed amniotic epithe
15、lial cells”) in Mol. Pharmacol. 69, 796(2006), Endocrinology 147, 2490 (2006) and J. Biol. Chem. 278, 31731 (2003) Chang liver (described as “normal liver cells”) in Oncogene 28, 3526 (2009), Proteomics 14, 2885(2008) a
16、nd J. Biol. Chem. 279, 28106 (2000) HEp-2 (described as “l(fā)aryngeal cancer”) in Investig. New Drugs 26, 111–118 (2008),Carcinogenesis 29, 1519 (2008) and J. Biol. Chem. 283, 36272 (2008)KB (described as “oral cancer”) i
17、n Biochem. Pharmacol. 73,1901–1909 (2007), Clin. Cancer Res. 14,8161(2008) and J. Biol. Chem. 280, 23829 (2005)HeLa, Int-407 and HEp-2 cells were used as three distinct cell lines in the same study in CancerRes. 69, 632
18、 (2009),Ecv-304,“人臍靜脈內(nèi)皮細(xì)胞”,日本實(shí)驗(yàn)室建立,ATCC、DSMZ等機(jī)構(gòu)有保藏,在1999—2000年,經(jīng)STR檢測(cè),證明為T(mén)24(膀胱癌),各自網(wǎng)站有公布。在實(shí)驗(yàn)室間廣泛傳播,2006y,全世界600余論文,利用該細(xì)胞進(jìn)行研究,2/3在中國(guó)。Why?Donot know? No other suitable cellular modelExpensieve, can not afford, have t
19、o compromise,Ecv-304/T24,對(duì)細(xì)胞質(zhì)量的要求,2007.10,Goslar, Germany,11ICCCScientist from ATCC proposed:(1)funding agencies,gov. or private require cell line authentication as a condition for the award of grant and contracts funds
20、. (2)key scientific J … as a condition for publication. (3) conference, workshop and/or training.(4)lab heads be encouraged to ensure QC measures. Authentic, Well characterizedThe problem of Sub-culturing,NIH NOTICE,20
21、07.12,Require cell anthenticationFor grantFor paper,雜志及細(xì)胞使用者的要求Examples 1,Thp-1, 2009-1-5cell line authentication, characterization and freedom from contamination This is an important issue, to which authors should
22、 pay particular attention. It is the authors' responsibility to ensure that cell lines used in any study (and the majority do involve them) are certified as being the designated type, that they have been checked to e
23、nsure they are free of contamination (e.g. mycoplasma), and that they have been used from young stock. These are the three criteria upon which good practice is based, as set out in the UKCCC Guidelines on the use of cell
24、 lines ( http://ukcccr.icnet.uk). Attention should be paid to this in the Material and Methods section, and authors omitting to include evidence of good practice will find that their articles may be delayed until such gu
25、arantees are given.,Example 2, Reporting on Cell Line Use in AACR Journals,NEW! EFFECTIVE JULY 1, 2009 AACR strongly encourages the authentication of cell lines used in the research reported in its journals.
26、If cell lines were used in the research, a statement addressing the following points must be included in the "Materials and Methods" section: 1. From where and when the cells were obtai
27、ned 2. Whether the cell lines have been tested and authenticated 3. The method by which the cells were tested 4. How and when the cells were last
28、 tested,AACR Journals,Cancer Research Clinical Cancer Research Cancer Epidemiology, Biomarkers & Prevention, CEBP Cancer Prevention Research Molecular Cancer Research Molecular Cancer Therapeutics Cancer Review
29、s Online Prevention Portal,Example 2—shelf life,If cells were obtained directly from a cell bank that performs cell line characterizations and passaged in the user's laboratory for fewer than 6 months after rec
30、eipt or resuscitation, re-authorization is not required. In these cases, please include the method of characterization used by the cell bank.If cells were obtained directly from a cell bank that performs cell line chara
31、cterizations and passaged in the user's laboratory for fewer than 6 months after receipt or resuscitation, re-authorization is not required. In these cases, please include the method of characterization used by
32、the cell bank.,Key milestones in the effort to address cell line misidentification,Hela cell line establishedfrom Henrietta Lacks,ATCC, American Type Culture Collection. NIH National Institutes of Health.STR, Short Tan
33、dem Repeat,Interspecies cross-Contaminationshown,ATCC starts Curating cell lines,Stan Gartler shows intraspeciesCross-contamination betweenHuman cell lines,Nelson-Ross confirms & estends Stan Gartler’s findings
34、,John Maddox describesIndividual like Nelson-RossAs self-appointed vigilantes,1981-2005 crossContamination spreeds Beyongd HeLa cells,NIH terminatescontract of Nelson-Ross,NIH issues guidelinesTo avoid the use of
35、misidentified cell lines,Roland Nardone starts the Second crusade agsinst Corss contamination,Nature calls for aGlobal database ofCell lines STR profies,,1952 1958 1962 1966 1974 1980 1981
36、 2005 2007 2009,,,,,,,,,,,,Hela cell line establishedfrom Henrietta Lacks,ATCC starts Curating cell lines,,Hela cell line establishedfrom Henrietta Lacks,ATCC starts Curating cell lines,,,Hela cell line e
37、stablishedfrom Henrietta Lacks,ATCC starts Curating cell lines,Nelson-Ross confirms & estends Stan Gartler’s findings,,,Hela cell line establishedfrom Henrietta Lacks,ATCC starts Curating cell lines,,Nelson-Ross
38、 confirms & estends Stan Gartler’s findings,,,Hela cell line establishedfrom Henrietta Lacks,ATCC starts Curating cell lines,,,Nelson-Ross confirms & estends Stan Gartler’s findings,,,Hela cell line establish
39、edfrom Henrietta Lacks,ATCC starts Curating cell lines,1981-2005 crossContamination spreeds Beyongd HeLa cells,,,Nelson-Ross confirms & estends Stan Gartler’s findings,,,Hela cell line establishedfrom Henrietta
40、 Lacks,ATCC starts Curating cell lines,NIH issues guidelinesTo avoid the use of misidentified cell lines,1981-2005 crossContamination spreeds Beyongd HeLa cells,,,Nelson-Ross confirms & estends Stan Gartler’s f
41、indings,,,Hela cell line establishedfrom Henrietta Lacks,ATCC starts Curating cell lines,,1952 1958 1962 1966 1974 1980 1981 2005 2007 2009,,Interspecies cross-Contaminationshow
42、n,1952 1958 1962 1966 1974 1980 1981 2005 2007 2009,,Stan Gartler shows intraspeciesCross-contamination betweenHuman cell lines,Interspecies cross-Contaminationshown,1952 195
43、8 1962 1966 1974 1980 1981 2005 2007 2009,,,Stan Gartler shows intraspeciesCross-contamination betweenHuman cell lines,Interspecies cross-Contaminationshown,1952 1958 1962
44、 1966 1974 1980 1981 2005 2007 2009,,John Maddox describesIndividual like Nelson-RossAs self-appointed vigilantes,,Stan Gartler shows intraspeciesCross-contamination betweenHuman cell li
45、nes,Interspecies cross-Contaminationshown,1952 1958 1962 1966 1974 1980 1981 2005 2007 2009,,,John Maddox describesIndividual like Nelson-RossAs self-appointed vigilantes,,Stan
46、Gartler shows intraspeciesCross-contamination betweenHuman cell lines,Interspecies cross-Contaminationshown,1952 1958 1962 1966 1974 1980 1981 2005 2007 2009,,NIH terminatescon
47、tract of Nelson-Ross,,John Maddox describesIndividual like Nelson-RossAs self-appointed vigilantes,,Stan Gartler shows intraspeciesCross-contamination betweenHuman cell lines,Interspecies cross-Contaminationshown,
48、1952 1958 1962 1966 1974 1980 1981 2005 2007 2009,,,NIH terminatescontract of Nelson-Ross,,John Maddox describesIndividual like Nelson-RossAs self-appointed vigilantes,,Stan Gar
49、tler shows intraspeciesCross-contamination betweenHuman cell lines,Interspecies cross-Contaminationshown,1952 1958 1962 1966 1974 1980 1981 2005 2007 2009,,Roland Nardone starts
50、 the Second crusade agsinst Corss contamination,,NIH terminatescontract of Nelson-Ross,,John Maddox describesIndividual like Nelson-RossAs self-appointed vigilantes,,Stan Gartler shows intraspeciesCross-contaminat
51、ion betweenHuman cell lines,Interspecies cross-Contaminationshown,1952 1958 1962 1966 1974 1980 1981 2005 2007 2009,,,Roland Nardone starts the Second crusade agsinst Corss con
52、tamination,,NIH terminatescontract of Nelson-Ross,,John Maddox describesIndividual like Nelson-RossAs self-appointed vigilantes,,Stan Gartler shows intraspeciesCross-contamination betweenHuman cell lines,Interspeci
53、es cross-Contaminationshown,1952 1958 1962 1966 1974 1980 1981 2005 2007 2009,,Nature calls for aGlobal database ofCell lines STR profies,,Roland Nardone starts the Second crus
54、ade agsinst Corss contamination,,NIH terminatescontract of Nelson-Ross,,John Maddox describesIndividual like Nelson-RossAs self-appointed vigilantes,,Stan Gartler shows intraspeciesCross-contamination betweenHuman
55、 cell lines,Interspecies cross-Contaminationshown,1952 1958 1962 1966 1974 1980 1981 2005 2007 2009,,,Requirements for cell authentication,Morphology check by microscopeGrowth cu
56、rve analysis Detection of mycoplasmaSpecies verification by IsoenzymologyIdentity verification with STR analysisSpecific properties conformation,Detection of cross-comtamination,STR PROFILING METHODOLOGY,ADVANTAGES,,
57、How to avoid cross-contaminations,Cell cultures received from sources other than recognized cell banks should generally be tested for identity, contaminations, and suitability of the cells for the assays planed. The myc
58、oplasma and cross-contaminations can also occur during cultivation and therefore the cell culture quality tests should be performed at regular intervals. Simultaneous handling of different cultures under the laminar f
59、low hood by one or more persons the use of a single flask of medium for different cell lines. The prophylactic use of antibiotic Avoid the negligent and erroneous labelling of cell culture vessels and cryo-ampoules.
60、,Resources for Authors,UKCCCR Guidelines for the Use of Cell Lines in Cancer Research, British J of Cancer (2000) 82(9); 1495–1509. Cell Line Verification Test Recommendations, ATCC Technical Bulletin No. 8 (2008).
61、 Cell Line Authentication Methods Cabrera CM et al., Identity Test: Determination of Cell Line Cross-Contamination, Cytotechnology (2006) 51:45–50. Masters JR et al., Short Tandem Repeat Profiling Provides an Internat
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫(kù)僅提供信息存儲(chǔ)空間,僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 喉癌細(xì)胞系腫瘤側(cè)群細(xì)胞的研究.pdf
- 表達(dá)HBX的人正常肝細(xì)胞和肝腫瘤細(xì)胞系的建立.pdf
- 大菱鲆腦細(xì)胞系和精巢細(xì)胞系的建立與鑒定.pdf
- 肺癌A549和H446細(xì)胞系腫瘤始發(fā)細(xì)胞的實(shí)驗(yàn)研究.pdf
- 肝癌細(xì)胞系中腫瘤干細(xì)胞樣細(xì)胞的初步研究.pdf
- 藤黃酸抗淋系腫瘤細(xì)胞系的作用及分子機(jī)制研究.pdf
- 胃癌細(xì)胞系SGC-7901腫瘤干細(xì)胞的初步研究.pdf
- 船用鋼板的質(zhì)量控制
- 肺癌細(xì)胞系中腫瘤干細(xì)胞樣細(xì)胞的分離鑒定和干性標(biāo)志的測(cè)定.pdf
- 質(zhì)量控制資料用表
- 太湖豬成纖維細(xì)胞系和前脂肪細(xì)胞系的建立及前脂肪細(xì)胞的分化研究.pdf
- 質(zhì)量控制方針和質(zhì)量控制目標(biāo)
- 轉(zhuǎn)爐煉鋼用廢鋼的質(zhì)量控制
- 阿司匹林對(duì)犬乳腺腫瘤細(xì)胞系CHMp和CHMm體內(nèi)外抑制機(jī)制研究.pdf
- 人卵巢癌細(xì)胞系OVCAR3的腫瘤干細(xì)胞的分離培養(yǎng)和鑒定.pdf
- 劍尾魚(yú)腦細(xì)胞系和胚胎細(xì)胞系的建立及苯并(a)芘對(duì)其脅迫效應(yīng)的研究.pdf
- 人淚腺腺樣囊性癌細(xì)胞系異種種植研究及其腫瘤干細(xì)胞的分離培養(yǎng)和鑒定.pdf
- 低溫脅迫對(duì)草魚(yú)ZC-7901細(xì)胞系和淡水白鯧CBS細(xì)胞系某些細(xì)胞功能影響的研究.pdf
- 質(zhì)量控制準(zhǔn)則的新變化及其要求
- 人胚胎干細(xì)胞系與人孤雌胚胎干細(xì)胞系建立的研究.pdf
評(píng)論
0/150
提交評(píng)論